title: Permissive nicotine regulation as a complement to traditional tobacco control.
abstract: BACKGROUND
  Cigarette smoking takes a staggering toll on human health and attracts considerable public health attention, yet real solutions seem distant. The 2004 Family Smoking Prevention and Tobacco Control Act (US Senate bill S2461) would have given the US Food and Drug Administration limited authority to regulate cigarettes to "protect the public health." However, such legislation is unlikely to substantially reduce smoking or related deaths.
  
  
  CONCLUSIONS
  The past 500 years of tobacco control efforts demonstrate that nicotine prohibition is a practical impossibility for numerous reasons, state revenue being one of the most ominous. The FDA already has regulatory authority over pharmaceutical grade nicotine products, and requires pharmacists to dispense the most addictive of these only with prescriptions. Meanwhile, every corner store can sell far more addictive and dangerous cigarettes to any adult. The FDA could immediately increase competition between cigarettes and clean nicotine products by approving available nicotine products for over-the-counter sales to adults. Similarly permissive regulation of cigarettes and addictive nicotine products will reduce tobacco use and improve smokers' health, but increase nicotine use in the population. Fortunately, restricted youth access and accurate labeling of nicotine's absolute risks will dissuade many non-smokers from experimenting with it, while accurate depiction of its risks relative to cigarette smoking will encourage many smokers to switch. The FDA could take a series of small steps that might ultimately replace a large proportion of cigarette smoking with equally addictive nicotine products, without risking serious public health setbacks. Vaccine, methadone, and injury prevention policies establish relevant public health precedents.
  
  
  CONCLUSIONS
  Cigarettes, or an equally addictive alternative, will be a permanent and common product in most societies. Regulations restricting only the safest addictive nicotine products are hard to justify. Addictive nicotine compliments other tobacco control strategies. Modern tobacco control policies are applicable to addictive nicotine. Controlled trials and test market studies are urgently needed to evaluate addictive nicotine as an alternative to smoking. Meanwhile, legislators should preserve the Food and Drug Administration's option to permit non-prescription sales of addictive nicotine.
authors.affiliation: Department of Medicine, Washington University School of Medicine, St, Louis, Missouri, USA. wsumner@im.wustl.edu
authors.forename: Walton
authors.initials: W
authors.lastname: Sumner
mesh_terms: D033161:Government Regulation; D006801:Humans; D009538:Nicotine / Q000592:standards*; D011634:Public Health; D012449:Safety; D000074606:Smoking Prevention; D011049:Social Control Policies; D019460:Tobacco Industry / Q000331:legislation & jurisprudence*; D020340:Tobacco Use Cessation; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D009538:Nicotine
references.citation: JAMA. 2000 Dec 20;284(23):2995-6
references.pmid: 11122580
references.citation: N Z Med J. 2004 Mar 12;117(1190):U801
references.pmid: 15107904
references.citation: Addiction. 2002 Oct;97(10):1347-54
references.pmid: 12359039
references.citation: Food Drug Law J. 1998;53 suppl:75-114
references.pmid: 10342981
references.citation: Head Neck. 2001 Oct;23(10):860-70
references.pmid: 11592233
references.citation: Addiction. 1997 May;92(5):615-33
references.pmid: 9219386
references.citation: Eur J Pharmacol. 2002 Apr 19;441(1-2):115-25
references.pmid: 12007928
references.citation: Psychopharmacology (Berl). 1998 Oct;139(3):288-90
references.pmid: 9784088
references.citation: Tob Control. 2003 Jun;12(2):124-32
references.pmid: 12773720
references.citation: Pharmacol Biochem Behav. 2001 Dec;70(4):561-70
references.pmid: 11796154
references.citation: Behav Genet. 1999 Nov;29(6):423-31
references.pmid: 10857247
references.citation: Curr Opin Investig Drugs. 2004 Apr;5(4):430-5
references.pmid: 15134285
references.citation: Arch Dis Child. 1995 Dec;73(6):549-51
references.pmid: 8546517
references.citation: J Environ Pathol Toxicol Oncol. 1996;15(2-4):169-72
references.pmid: 9216801
references.citation: Arch Environ Health. 1995 Sep-Oct;50(5):384-9
references.pmid: 7574894
references.citation: Br Med Bull. 1996 Jan;52(1):58-73
references.pmid: 8746297
references.citation: Chest. 1996 Feb;109(2):438-45
references.pmid: 8620719
references.citation: Tob Control. 2003 Dec;12(4):372-3
references.pmid: 14660770
references.citation: J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):630-41
references.pmid: 11392340
references.citation: J Toxicol Clin Toxicol. 1996;34(6):691-8
references.pmid: 8941198
references.citation: Alcohol Clin Exp Res. 1995 Oct;19(5):1111-20
references.pmid: 8561278
references.citation: Addiction. 2001 Dec;96(12):1757-68
references.pmid: 11784468
references.citation: Tob Control. 2003 Jun;12 Suppl 1:i14-24
references.pmid: 12773782
references.citation: JAMA. 2002 Sep 11;288(10):1260-4
references.pmid: 12215133
references.citation: Addiction. 2000 Jan;95 Suppl 1:S25-8
references.pmid: 10723819
references.citation: Am J Med Sci. 1994 Jul;308(1):32-4
references.pmid: 8010334
references.citation: Lancet. 2003 Sep 13;362(9387):847-52
references.pmid: 13678970
references.citation: Food Drug Law J. 1998;53 suppl:1-8
references.pmid: 10342978
references.citation: Ann Vasc Surg. 1998 Jan;12(1):41-5
references.pmid: 9451995
references.citation: Inj Prev. 2000 Dec;6(4):277-80
references.pmid: 11144627
references.citation: Nicotine Tob Res. 2003 Apr;5(2):237-43
references.pmid: 12745497
references.citation: JAMA. 1997 Oct 1;278(13):1087-92
references.pmid: 9315768
references.citation: Calcif Tissue Int. 1999 Sep;65(3):246-9
references.pmid: 10441660
references.citation: Expert Opin Emerg Drugs. 2004 May;9(1):39-53
references.pmid: 15155135
references.citation: Health Psychol. 1998 Jan;17(1):56-62
references.pmid: 9459071
references.citation: Psychol Addict Behav. 2003 Dec;17(4):332-5
references.pmid: 14640830
references.citation: Ann Intern Med. 1997 Mar 1;126(5):364-71
references.pmid: 9054280
references.citation: Am J Public Health. 2000 Mar;90(3):401-3
references.pmid: 10705858
references.citation: MMWR Morb Mortal Wkly Rep. 2003 Sep 5;52(35):842-4
references.pmid: 12966360
references.citation: Br J Obstet Gynaecol. 1996 Aug;103(8):806-13
references.pmid: 8760712
references.citation: Nicotine Tob Res. 2000 Feb;2(1):45-52
references.pmid: 11072440
references.citation: MMWR Morb Mortal Wkly Rep. 2002 Jul 26;51(29):642-5
references.pmid: 12186222
references.citation: Tob Control. 2003 Dec;12(4):349-59
references.pmid: 14660766
references.citation: Tob Control. 1997 Autumn;6(3):254-61
references.pmid: 9396113
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):178-82
references.pmid: 7552882
references.citation: Epidemiol Rev. 2003;25:60-4
references.pmid: 12940231
references.citation: Psychopharmacology (Berl). 1994 Nov;116(3):382-4
references.pmid: 7892431
references.citation: Br J Addict. 1991 May;86(5):653-8
references.pmid: 1859935
references.citation: Crit Rev Oral Biol Med. 2004;15(5):252-63
references.pmid: 15470264
references.citation: Br J Addict. 1990 Feb;85(2):279-91
references.pmid: 2180511
references.citation: J Pharmacol Exp Ther. 1998 Jun;285(3):931-45
references.pmid: 9618392
references.citation: Semin Perinatol. 1996 Apr;20(2):115-26
references.pmid: 8857697
references.citation: Mutat Res. 2002 Nov 26;521(1-2):137-49
references.pmid: 12438011
references.citation: Annu Rev Pharmacol Toxicol. 1996;36:597-613
references.pmid: 8725403
references.citation: Life Sci. 1996;58(16):1339-46
references.pmid: 8614291
references.citation: Soc Sci Med. 1991;32(9):989-1005
references.pmid: 2047903
references.citation: J Trauma. 1972 Mar;12(3):193-207
references.pmid: 5012817
references.citation: Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):152S-156S
references.pmid: 11391065
references.citation: Physiol Behav. 2001 Sep 1-15;74(1-2):213-26
references.pmid: 11564471
references.citation: Nicotine Tob Res. 2002;4 Suppl 2:S61-71
references.pmid: 12580158
references.citation: South Med J. 1993 Sep;86(9):989-92
references.pmid: 8367763
references.citation: Food Drug Law J. 1998;53 suppl:11-42
references.pmid: 10342979
references.citation: Science. 1976 Dec 11;194(4271):1243-6
references.pmid: 996552
references.citation: Food Drug Law J. 1998;53 suppl:43-74
references.pmid: 10342980
references.citation: FASEB J. 1993 Aug;7(11):1045-51
references.pmid: 8370474
references.citation: MMWR Morb Mortal Wkly Rep. 2003 Apr 11;52(14):303-4, 306-7
references.pmid: 12731700
references.citation: Tob Control. 2003 Dec;12(4):360-7
references.pmid: 14660767
references.citation: Drug Saf. 2001;24(4):277-322
references.pmid: 11330657
references.citation: Psychopharmacology (Berl). 1999 Sep;146(2):199-204
references.pmid: 10525756
references.citation: Acta Paediatr Suppl. 1993 Jun;82 Suppl 389:70-2
references.pmid: 8374198
references.citation: Toxicol Appl Pharmacol. 2002 Jan 1;178(1):8-14
references.pmid: 11781074
references.citation: Lancet. 2003 Dec 6;362(9399):1865
references.pmid: 14667736
references.citation: World J Biol Psychiatry. 2003 Apr;4(2):49-55
references.pmid: 12692774
references.citation: Psychoneuroendocrinology. 1998 Feb;23(2):175-87
references.pmid: 9621397
references.citation: Tob Control. 2001 Sep;10(3):201-3
references.pmid: 11544374